SG&A expenses increased in the three months ended September 30, 2011 by $2.3 million from the comparable prior year period. The increase is primarily due to an increase in employee compensation expenses, which included performance-based programs and costs related to increased headcount.
RD&E for the three months ended September 30, 2011 increased by $0.7 million compared with the prior year period. Overall, spending as a percentage of sales decreased due to increased sales volume. The addition of our EPO group contributed $0.2 million to RD&E in the first quarter of fiscal 2012. Our product development efforts will continue across all product lines.
Other income (expense) for the three months ended September 30, 2011 decreased by $0.5 million over the prior year balance, primarily due to a $0.2 million unrealized loss in a mutual fund related to our deferred compensation program and interest expense of $0.2 million related to the future consideration in connection with our acquisition of ASML US, Inc.’s Richmond, California assets.
The effective income tax rates of 10% and 17% for the quarters ended September 30, 2011 and 2010, respectively, differ from the domestic statutory rate principally due to available net operating loss (“NOL”) carryforwards and the valuation allowances on these NOL’s and from foreign tax rates, which are overall lower than in the U.S. The fiscal 2012 income tax rate was lower than the fiscal 2011 rate due to a higher percentage of our income being derived from U.S. operations than in the prior year, enabling us to utilize more of our NOL carryforwards.
In 2010, we established a valuation allowance against substantially all our net deferred assets based upon the consideration of all available evidence. As of September 30, 2011, we have concluded that we should continue to maintain valuation allowances on substantially all of our net deferred tax assets. In future periods, the valuation allowances could be reduced based upon sufficient evidence indicating that it is more likely than not that a portion of the deferred tax assets will be realized.
| | | | | | | | | | | | | |
Earnings from Discontinued Operations, net of tax | | | | | | | | | | | | | |
| | Fiscal 2012 | | Fiscal 2011 | |
| |
| |
| |
(Dollars in millions) | | Amount | | Percentage of Net Revenues | | Amount | | Percentage of Net Revenues | |
| |
| |
| |
| |
| |
| | | | | | | | | | | | | |
Quarter ended September 30 | | $ | — | | | 0 | % | $ | 0.1 | | | 0 | % |
The earnings from discontinued operations for the three months ended September 30, 2010 of $0.1 was due to final adjustments related to the closure of our Singapore IC packaging operations of our Vision Systems product line.
TRANSACTIONS WITH STOCKHOLDER
Revenues from Canon Inc., a stockholder, and Canon Sales Co., Inc., a distributor of certain of our products in Japan and a subsidiary of Canon Inc. (collectively referred to as “Canon”), amounted to $4.8 million and $3.5 million (11% of net revenues each) for the three months ended September 30, 2011 and 2010, respectively. Selling prices of products sold to Canon are based, generally, on the terms customarily given to distributors. At September 30, 2011 and June 30, 2011, there were, in the aggregate, $2.1 million and $2.6 million, respectively, of trade accounts receivable from Canon.
LIQUIDITY AND CAPITAL RESOURCES
We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. Our principal source of liquidity is our cash reserves and operating cash flows. In addition to operating cash flows, other significant factors that affect our overall management of liquidity include: capital expenditures, customer credit requirements, investments in businesses and the availability of bank lines of credit.
At September 30, 2011, cash and short-term marketable securities were $63.9 million, an increase of $2.9 million from $61.0 million at June 30, 2011, of which $14.5 million is located in foreign jurisdictions subject to repatriation restrictions. Our short-term marketable securities consists of $1.0 million in a United States Treasury Bill. The cash equivalents balance in our money market account, which is invested primarily in U.S. government securities, was $19.9 million as of September 30, 2011. We do not believe there is any risk to liquidity in the money market account, nor are there currently any limits on redemptions.
Cash flows provided by operating activities from continuing operations for the three months ended September 30, 2011 of $5.0 million was primarily due to an increase in net earnings and a reduction in inventory partially offset by a decrease in accrued expenses and an increase in accounts receivable. The reduction in inventory is primarily related to large shipments of our products in the quarter and inventory management. The decrease in accrued expenses is primarily related to payments for incentive compensation and profit-sharing programs. Accounts receivable increased $1.8 million from June 30, 2011 and $9.9 million from September 30, 2010 and days sales outstanding on accounts receivable increased to 65 days at September 30, 2011 from 63 days at June 30, 2011 and 62 days at September 30, 2010 primarily due to timing of increased shipments in the quarter.
Cash flows used for investing activities for the three months ended September 30, 2011 of $0.4 million was related to the purchase of property, plant and equipment.
Cash flows used for financing activities in the three months ended September 30, 2011 of $0.9 million remained essentially flat compared with the prior year period. For the three months ended September 30, 2011, there were dividend payments of $0.7 million to a noncontrolling interest and $0.3 million for the repurchase of restricted stock, partially offset by an increase of $0.1 million in proceeds from stock option exercises.
We currently have no lines of credit. In the future, if the need for debt or credit lines arises there is no assurance that we would be able to secure such financing. We believe we have sufficient cash flows from operations and cash reserves to maintain adequate amounts of liquidity and to meet our future liquidity requirements for at least the next twelve months.
22
OFF-BALANCE SHEET ARRANGEMENTS
We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt, or operating parts of our business that are not consolidated into our financial statements. We have not guaranteed any obligations of a third party.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes in our quantitative and qualitative market risk disclosures during the three months ended September 30, 2011. Please refer to Item 7a., “Quantitative and Qualitative Disclosures about Market Risk,” of our Annual Report on Form 10-K for the year ended June 30, 2011, filed with the Securities and Exchange Commission (the “2011 Annual Report”) for a discussion of our exposure to market risk.
Item 4. Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation, as of the end of the period covered by this report, of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon their evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of such period, our disclosure controls and procedures were effective.
There were no changes in our internal control over financial reporting that occurred in our most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
23
PART II - Other Information
Item 1A. Risk Factors
Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended June 30, 2011 includes a listing of risk factors that could materially affect our business, financial condition, or future results. There have been no material changes in our risk factors from those set forth in our Annual Report on Form 10-K for the year ended June 30, 2011; however, the risks described in our 2011 Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information about our purchases during the quarter ended September 30, 2011 of equity securities that are registered by us pursuant to Section 12 of the Securities Exchange Act of 1934.
| | | | | | | | | | | | | |
Period | | Total number of shares purchased | | Average price paid per share | | Total number of shares purchased as part of publicly announced plans or programs (1) | | Approximate dollar value of shares that may yet be purchased under the plans or programs (in millions) | |
| |
| |
| |
| |
| |
| | | | | | | | | | | | | |
July 1, 2011 - July 31, 2011 | | | — | | | n/a | | | — | | $ | 5.0 | |
August 1, 2011 - August 31, 2011 | | | 30,448 | | $ | 9.83 | | | — | | $ | 5.0 | |
September 1, 2011 - September 30, 2011 | | | — | | | n/a | | | — | | $ | 5.0 | |
| | |
| (1) | In August 2007, our Board of Directors authorized the repurchase of up to $25.0 million of our outstanding common stock. During the three months ended September 30, 2011, there were no repurchases of common stock in the open market. These historical share repurchases have been effected pursuant to plans in conformity with Rule 10b5-1 under the Securities Exchange Act of 1934. This rule allows public companies to adopt written, pre-arranged stock trading plans when they do not have material, non-public information in their possession. The adoption of this stock trading plan allows us to repurchase our shares during periods when we otherwise might be prevented from doing so under insider trading laws or because of self-imposed trading blackout periods. |
24
Item 6. Exhibits
| | |
(a) | Exhibits: |
| |
| 31.1 | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
| 31.2 | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
| 32.1 | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| | |
| 32.2 | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| | |
| 101. INS* XBRL Instance Document |
| |
| 101. SCH* XBRL Taxonomy Extension |
| |
| 101. CAL* XBRL Taxonomy Extension Calculation Linkbase |
| |
| 101. DEF* XBRL Taxonomy Extension Definition Linkbase |
| |
| 101. LAB* XBRL Taxonomy Extension Label Linkbase |
| |
| 101. PRE* XBRL Taxonomy Extension Presentation Linkbase |
*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
25
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
| Zygo Corporation |
|
|
| (Registrant) |
| |
| /s/ Chris L. Koliopoulos |
|
|
| Chris L. Koliopoulos |
| Chairman, President and Chief Executive Officer |
| |
| /s/ John P. Jordan |
|
|
| John P. Jordan |
| Vice President, Chief Financial Officer and Treasurer |
Date: November 9, 2011
26
EXHIBIT INDEX
| |
31.1 | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| |
31.2 | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| |
32.1 | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| |
32.2 | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| |
101. INS* XBRL Instance Document |
|
101. SCH* XBRL Taxonomy Extension |
|
101. CAL* XBRL Taxonomy Extension Calculation Linkbase |
|
101. DEF* XBRL Taxonomy Extension Definition Linkbase |
|
101. LAB* XBRL Taxonomy Extension Label Linkbase |
|
101. PRE* XBRL Taxonomy Extension Presentation Linkbase |
*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.